Safety, pharmacokinetics, and pharmacodynamics of intravenously administered deuterated N,N-dimethyltryptamine (CYB004) in healthy volunteers

Paper. van der Heijden KV, Jacobs GE, James EH et al.. Journal of Psychopharmacology, 3 Sep 2026.

Tags: Human, DMT.

Weekly Science Digest, 29 Aug 2026 to 4 Sep 2026, finding 3: Dose-finding is still the bottleneck

Two DMT dosing studies hit participant withdrawals at the high end.

CYB004, a deuterated DMT built for a steadier profile, was only acceptably tolerated at plasma concentrations matching plain DMT; a separate intravenous DMT study had two subjects stop their infusion for anxiety. A 20-person crossover compared whole-mushroom oral psilocybin, oral psilocin and sublingual psilocin.

Read the original

—
Node—
Statuslive
Throughput—